Lee's Pharmaceutical Holdings (HKSE:00950) Accumulated other comprehensive income (loss) : HK$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Lee's Pharmaceutical Holdings Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Lee's Pharmaceutical Holdings's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was HK$0.0 Mil.

Lee's Pharmaceutical Holdings Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Accumulated other comprehensive income (loss) Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

Lee's Pharmaceutical Holdings Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-	-	-	-	-

Lee's Pharmaceutical Holdings Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Lee's Pharmaceutical Holdings Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings (HKSE:00950) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (HKSE:00950) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hong Kong Science Park, Shatin, 1/Floor, Building 20E, Phase 3, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a Cayman Island-based research-driven and market-oriented biopharmaceutical company. It is integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales, and marketing in China with global perspectives. It focuses on cardiovascular, woman's health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. Its portfolio has two categories of Proprietary products and Licensed-in products. Its maximum revenue is generated from China. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Eyprotor. Its Licensed-in Products include Carnitene, Ferplex, ALOXI, and Centraxal Plus, among others.

Lee's Pharmaceutical Holdings (HKSE:00950) Headlines

No Headlines